Drug Company Reaches $13M Settlement With SEC Over Accounting Fraud Claims
WASHINGTON, D.C. — Medical manufacturer Alere Inc. will pay more than $13 million to settle claims with the Securities and Exchange Commission that it engaged in accounting fraud and made improper...To view the full article, register now.
Already a subscriber? Click here to view full article